Annovera was launched in 2018 in USA. Well
established product in Pharma. TherapeuticsMD
total revenue as stated was small. Total combined
for first 9 months 2022 was $68m. That’s all the
products.
- Forums
- ASX - By Stock
- MYX
- Ann: MYX signs license agreement for women's health products
Ann: MYX signs license agreement for women's health products, page-104
-
- There are more pages in this discussion • 94 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.36 |
Change
-0.040(0.91%) |
Mkt cap ! $369.2M |
Open | High | Low | Value | Volume |
$4.42 | $4.45 | $4.23 | $681.8K | 156.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 1455 | $4.35 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.37 | 839 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 1365 | 4.340 |
9 | 9818 | 4.330 |
7 | 2301 | 4.320 |
5 | 2657 | 4.310 |
4 | 4405 | 4.300 |
Price($) | Vol. | No. |
---|---|---|
4.360 | 602 | 2 |
4.370 | 2498 | 7 |
4.380 | 876 | 6 |
4.390 | 976 | 6 |
4.400 | 564 | 3 |
Last trade - 15.10pm 15/07/2024 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online